bluebird bio Inc. (NASDAQ: BLUE) stock closed at 28.28 per share at the end of the most recent trading day (a -4.85% change compared to the prior day closing price) with a volume of 2.45M shares and market capitalization of 1.90B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1213 people. bluebird bio Inc. CEO is Nick Leschly.

The one-year performance of bluebird bio Inc. stock is -46.19%, while year-to-date (YTD) performance is -34.64%. BLUE stock has a five-year performance of -43.87%. Its 52-week range is between 24.24 and 72.5, which gives BLUE stock a 52-week price range ratio of 8.37%

bluebird bio Inc. currently has a PE ratio of -2.90, a price-to-book (PB) ratio of 1.43, a price-to-sale (PS) ratio of 8.21, a price to cashflow ratio of 5.70, a PEG ratio of 2.32, a ROA of -33.79%, a ROC of -38.67% and a ROE of -44.93%. The company’s profit margin is -%, its EBITDA margin is -253.70%, and its revenue ttm is $228.87 Million , which makes it $3.41 revenue per share.

Of the last four earnings reports from bluebird bio Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-3.02 for the next earnings report. bluebird bio Inc.’s next earnings report date is 10th May 2021.

The consensus rating of Wall Street analysts for bluebird bio Inc. is Strong Buy (1.5), with a target price of $50.17, which is +77.40% compared to the current price. The earnings rating for bluebird bio Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

bluebird bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

bluebird bio Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.59, ATR14 : 2.26, CCI20 : -72.44, Chaikin Money Flow : -0.25, MACD : -2.88, Money Flow Index : 54.43, ROC : -1.19, RSI : 40.47, STOCH (14,3) : 17.94, STOCH RSI : 0.68, UO : 46.52, Williams %R : -82.06), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of bluebird bio Inc. in the last 12-months were: Alison Cecily Finger (Sold 2 102 shares of value $97 569 ), Andrew Obenshain (Sold 817 shares of value $23 660 ), David Davidson (Sold 4 376 shares of value $188 533 ), Douglas G. Cole (Sold 3 706 shares of value $163 401 ), Katy Burnett (Sold 641 shares of value $20 256 ), Kory J. Wentworth (Sold 832 shares of value $54 610 ), Nick Leschly (Sold 14 566 shares of value $685 783 ), Philip D. Gregory (Sold 3 974 shares of value $172 055 ), William D. Baird (Sold 2 858 shares of value $117 624 )